Lyka Labs soars 5% after clarifying over manufacturing of Remdesivir Injection

The company reacted to messages on social media it is having stock of Remdesivir Injection.

Apr 20, 2021 11:04 IST India Infoline News Service

Lyka Labs Limited clarified to exchanges on Monday that the company manufactures Remdesivir Injection on a contractual basis for other companies which place orders with our company.

“We do not sell Remdesivir Injection directly to Wholesalers / Retailers /Hospitals /Institutions,” the company said.

The company reacted to “false message” being circulated on various social media platforms including WhatsApp, “misleading” the public into believing that our company is having stock of Remdesivir Injection (medicine used for treatment of Covid-19 patients) and that the same can be purchased from our office at Spencer Building, Forjett Street; Tardeo, Grant Road, Mumbai.

At around 11.52 am, Lyka Labs Ltd was trading at Rs29.45 per piece up by Rs1.4 or 4.99% from its previous closing of Rs28.05 per piece on the BSE.

Related Story

Open Free Demat Account (Rs699)